Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-resistant Tablets, El(26)a/21
Recall Summary Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets distributed in the United Kingdom because the Patient Information Leaflet and carton packaging are missing text from sections 2 and 3. This recall affects patients in the UK who have these tablets.
- Recalling firm
- Omega Pharma Ltd
- Reason
- Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg Gastro-resistant tablets.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2026-04-24
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/1239daf2-3208-40d1-982f-a807444774b9